Bill > SB1230

This bill modifies Arizona's laws regarding medical marijuana clinical research by establishing mandatory funding and guidelines for marijuana research trials. The Arizona Biomedical Research Centre is now required to provide $2,000,000 from the medical marijuana fund for competitive grants by July 1, 2026, with a potential additional $2,000,000 by July 1, 2028 if the fund maintains sufficient operational expenses. The clinical trials must be approved by federal agencies like the FDA and DEA, conducted by Arizona-based nonprofit researchers or universities, and focus on studying marijuana's effects in treating conditions such as autism, epilepsy, post-traumatic stress disorder, and pain. The bill provides legal protection for researchers, ensuring they cannot be prosecuted for marijuana possession while conducting approved clinical trials. Importantly, the bill requires an affirmative vote of at least three-fourths of legislators in both houses to take effect, reflecting its significant policy changes in medical marijuana research. The legislation aims to advance scientific understanding of marijuana's medical potential through rigorous, federally-sanctioned research trials.

Budget and Finance, Health and Social Services

https://apps.azleg.gov/BillStatus/BillOverview/82579